← Leaderboards
Thomas G Graeber
University Of California Los Angeles
$11,122,033
Attributed
$18,316,837
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2005–24$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$18,316,837 · 9
By mechanism
R01$11,382,042 · 3
P01$4,790,883 · 3
K22$1,194,357 · 1
S10$593,168 · 1
R21$356,387 · 1
Top collaborators
- David A. Nathanson5 shared
- Owen N Witte5 shared
- Vaithilingaraja Arumugaswami2 shared
- Arjun Deb2 shared
- Matteo Pellegrini2 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Senta K Georgia$2,283,265
- Owen N Witte$15,146,055
- Michael A Teitell$22,516,970
- Jason C Reed$3,961,214
- Mary Catherine Cambou$610,740
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionTumorPhenotypeCell LineCancer CellTargeted TreatmentCellsGenomicsBioinformaticsProgramsSamplingBiological ModelsResistanceMutationBaseMalignant NeoplasmsMediatingPre-ClinicalBiologyGeneticGenetic TranscriptionInsightMetabolismIn Vivo
Grant awards (30)
Project 2: Targeting differentiation-linked redox sensitivity in melanoma$492,027
P01 · FY2024 · CA · contact PI
Metabolic and epigenetic reprogramming of vital organs in SARS-CoV-2 induced systemic toxicity$2,378,661
R01 · FY2023 · DK
Project 2: Targeting differentiation-linked redox sensitivity in melanoma$507,564
P01 · FY2023 · CA · contact PI
Mammalian models for integrated metabolic and molecular profiling of malignant glioma$543,028
R01 · FY2022 · CA
Targeting Genomic Instability in Lethal Neuroendocrine Prostate Cancer$519,628
R01 · FY2022 · CA · contact PI
Project 2: Targeting differentiation-linked redox sensitivity in melanoma$507,564
P01 · FY2022 · CA · contact PI
Metabolic and epigenetic reprogramming of vital organs in SARS-CoV-2 induced systemic toxicity$3,636,473
R01 · FY2021 · DK
Mammalian models for integrated metabolic and molecular profiling of malignant glioma$554,109
R01 · FY2021 · CA
Targeting Genomic Instability in Lethal Neuroendocrine Prostate Cancer$530,232
R01 · FY2021 · CA · contact PI
Project 2: Targeting differentiation-linked redox sensitivity in melanoma$517,922
P01 · FY2021 · CA · contact PI
Mammalian models for integrated metabolic and molecular profiling of malignant glioma$554,109
R01 · FY2020 · CA
Targeting Genomic Instability in Lethal Neuroendocrine Prostate Cancer$530,232
R01 · FY2020 · CA · contact PI
Project 2: Targeting differentiation-linked redox sensitivity in melanoma$517,922
P01 · FY2020 · CA · contact PI
Mammalian models for integrated metabolic and molecular profiling of malignant glioma$537,485
R01 · FY2019 · CA
Targeting Genomic Instability in Lethal Neuroendocrine Prostate Cancer$514,324
R01 · FY2019 · CA · contact PI
Mammalian models for integrated metabolic and molecular profiling of malignant glioma$553,813
R01 · FY2018 · CA
Targeting Genomic Instability in Lethal Neuroendocrine Prostate Cancer$529,948
R01 · FY2018 · CA · contact PI
INTEGRATED PROTEOMICS AND GENOMICS TO IDENTIFY CRITICAL SIGNALING EVENTS IN RESI$452,639
P01 · FY2017 · CA · contact PI
INTEGRATED PROTEOMICS AND GENOMICS TO IDENTIFY CRITICAL SIGNALING EVENTS IN RESI$452,639
P01 · FY2016 · CA · contact PI
INTEGRATED PROTEOMICS AND GENOMICS TO IDENTIFY CRITICAL SIGNALING EVENTS IN RESI$452,639
P01 · FY2015 · CA · contact PI
INTEGRATED PROTEOMICS AND GENOMICS TO IDENTIFY CRITICAL SIGNALING EVENTS IN RESI$439,061
P01 · FY2014 · CA · contact PI
Quantitative Mass Spectrometer for Targeted and Global Proteomics, Metabolomics$593,168
S10 · FY2013 · OD · contact PI
INTEGRATED PROTEOMICS AND GENOMICS TO IDENTIFY CRITICAL SIGNALING EVENTS IN RESI$450,906
P01 · FY2013 · CA · contact PI
Diagnosing Emergence of Kinase Inhibitor Resistance on a Microchip$188,912
R21 · FY2013 · CA · contact PI
Diagnosing Emergence of Kinase Inhibitor Resistance on a Microchip$167,475
R21 · FY2012 · CA · contact PI
Profiling of Protein Modifications by Mass Spectrometry$266,884
K22 · FY2007 · HG · contact PI
Profiling of Protein Modifications by Mass Spectrometry$263,956
K22 · FY2006 · HG · contact PI
Profiling of Protein Modifications by Mass Spectrometry$262,282
K22 · FY2005 · HG
Profiling of Protein Modifications by Mass Spectrometry$254,709
K22 · FY2004 · HG
Profiling of Protein Modifications by Mass Spectrometry$146,526
K22 · FY2003 · HG